Moussa B. H. Youdim

Moussa B.H. Youdim Moussa B. H. Youdim (born, February 28, 1940) is an Israeli neuroscientist specializing in neurochemistry and neuropharmacology. He is the discoverer of both monoamine oxidase (MAO) B inhibitors l-deprenyl (Selegiline) and rasagiline (Azilect) as anti-Parkinson drugs which possess neuroprotective activities. He is currently professor emeritus at Technion - Faculty of Medicine and President of Youdim Pharmaceuticals. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Moussa B. H. Youdim', query time: 0.02s Refine Results
  1. 1
    Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim

    Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim by Moussa B.H. Youdim

    Published 2015-10-01
    Get full text
    Article
  2. 2
    The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

    The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging by Lana Kupershmidt, Moussa B. H. Youdim

    Published 2023-02-01
    Get full text
    Article

Search Tools: